Opinion| UNIDO Egypt fosters manufacturing sector recovery in a changing economy    Opinion| Consequences of US withdrawal from Middle East    Cairo joins in 'Orange the World' campaign raising awareness on gender-based violence    EU, Egypt partner in supporting gender-targeted programmes: Ambassador Berger    Luiza Formenius launches new single 'I'll Be Home For Christmas'    Korean Ambassador urges need to enhance space cooperation with Egypt    Export-Import Bank of Korea delegation visits Cairo to chart Roadmap for future cooperation    Egypt renews call for nuclear weapon-free zone in Middle East    Wegz is most streamed artist in Egypt during 2021 for second consecutive year: Spotify    Orange Egypt Continues its Sponsorship for iRead Awards Ceremony    Egypt participates in 8th Forum on China-Africa Cooperation    Egypt, Qatar discuss cooperation in sports infrastructure    Poor sleep habits are associated with deficient control of blood sugar after meals    Prominent Egyptian anchor calls on UK to designate "Muslim Brotherhood" a Terrorist entity    Egypt, Israel sign deal sign MoU to increase gas supplies, hydrogen transport    Egypt's stocks end week in green as benchmark EWX 30 surges 0.69%    Mortada Mansour sets road map for Zamalek, after normalization committee depart    I seek to secure stable financial sources to build strong judo team: Motei Fakhr El-Din    Orascom Construction joins consortium to develop Egypt's first green hydrogen production facility    98 potential candidates run for Libyan presidency    'Lake Victoria – Mediterranean' navigation corridor awaits feasibility studies, funds: official    Egypt's trade with Nile basin countries climbs 26% y-o-y in 9 months    Egypt selected to host COP27 international climate conference in 2022    Number of British tourists to Egypt seen hitting 500,000 this winter – envoy    The unvaccinated prohibited from entry to Egypt state institutions starting December 1    Egypt, Greece ink deal for first subsea power link between Europe and Africa    SCOHRE sparks discussion on harm reduction, tobacco control    Egypt to receive first of six high-trains from Spain's Talgo in mid-November    Egypt's iron and steel exports jump 197% in 8 months    Ethiopia halts work at its embassy in Egypt for 'economic reasons'    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    Brazil calls up 8 EPL players for World Cup qualifying    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Sisi calls on House, Senate to commence second legislative sessions on 3, 5 October    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    Qa'a play showing at Lycee El Horreya Theatre, Alexandria is a must go    APO Group enters new exclusive agreement with Getty Images on African press releases and images    On International Museum Day, Egypt opens two new museums at Cairo Airport    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



UK scientists worried vaccines may not work on S.African coronavirus variant: ITV
Published in Ahram Online on 04 - 01 - 2021

Scientists are not fully confident that COVID-19 vaccines will work on a new variant of the coronavirus found in South Africa, ITV's political editor said on Monday, citing an unidentified scientific adviser to the British government.
Both Britain and South Africa have discovered new, more infectious variants in the coronavirus in recent weeks that have driven a surge in cases. British Health Secretary Matt Hancock said on Monday he was now very worried about the strand found in South Africa.
Scientists including BioNTech CEO Ugur Sahin and John Bell, Regius Professor of Medicine at the University of Oxford, have said they are testing the vaccines on the new variants and say they could make any required tweaks in around six weeks.
"According to one of the government's scientific advisers, the reason for Matt Hancock's 'incredible worry' about the South African COVID-19 variant is that they are not as confident the vaccines will be as effective against it as they are for the UK's variant," ITV political editor Robert Peston said.
Public Health England said there was currently no evidence to suggest that vaccines will not be effective against the new strain. The health ministry did not immediately respond to requests for comment on the report.
The world's richest countries have started vaccinating their populations to safeguard against a virus that has killed 1.8 million people and crushed the global economy.
There are currently 60 vaccine candidates in trials, including those that are already being rolled out from AstraZeneca and Oxford, Pfizer and BioNTech , Moderna, Russia's Sputnik V and China's Sinopharm.
That has helped to lift global financial markets, but the discovery of the new variants has raised fresh alarm.
Scientists say the new South African variant has multiple mutations in the important "spike" protein that the virus uses to infect human cells.
It has also been associated with a higher viral load, meaning a higher concentration of virus particles in patients' bodies, possibly contributing to higher levels of transmission.
Oxford's Bell, who advises the government's vaccine task force, said on Sunday he thought vaccines would work on the British variant but said there was a "big question mark" as to whether they would work on the South African variant.
He told Times Radio that the shots could be adapted and "it might take a month or six weeks to get a new vaccine".
BioNTech's Sahin told Spiegel in an interview published on Friday that their vaccine, which uses messenger RNA to instruct the human immune system to fight the coronavirus, should be able to cope with the variant first detected in Britain.
"We are testing whether our vaccine can also neutralise this variant and will soon know more," he said.
Asked about coping with a strong mutation, he said it would be possible to tweak the vaccine as required within six weeks - though it might require additional regulatory approvals.


Clic here to read the story from its source.